ISSN 3060-4745 Open Access · Peer Reviewed
PDF
DOI

Keywords

физиологик сариқлик
чақалоқлар
билирубин

How to Cite

ЯНГИ ТУҒИЛГАН ЧАҚАЛОҚЛАРДА ФИЗИОЛОГИК САРИҚЛИКНИНГ ЎСИШ ВА РИВОЖЛАНИШГА ТАЪСИРИ. (2024). ACUMEN: INTERNATIONAL JOURNAL OF MULTIDISCIPLINARY RESEARCH, 1(5), 404-407. https://www.universalpublishings.com/index.php/aijmr/article/view/9113

Abstract

Физиологик сариқлик янги туғилган чақалоқларда жуда кенг тарқалган ҳолат бўлиб, чақалоқлар жигарининг етишмовчилиги туфайли қонда билирубин миқдорининг ортиши натижасида юзага келади. Ушбу тадқиқотда билирубин миқдорининг юқори даражада бўлиши чақалоқларнинг мотор, когнитив ривожланишига ва жисмоний ўсишига салбий таъсир кўрсатиши таҳлил қилинди. Эрта аниқлаш ва фототерапия каби усуллар сариқликнинг салбий оқибатларини камайтиришда муҳим аҳамият касб этади.

PDF
DOI

References

1. Maisels MJ, Watchko JF. Neonatal jaundice and kernicterus. New England Journal of Medicine. 2003;358(9):920-928. doi:10.1056/NEJMra0801272.

2 Bhutani VK, Stark AR, Lazzeroni LC, et al. Management of hyperbilirubinemia in newborns: A guideline analysis. Pediatrics. 2013;114(1):297-316. doi:10.1542/peds.2013-0013.

3. Amin SB, Lamola AA. New developments in the management of neonatal jaundice and kernicterus. Pediatrics Clinics of North America. 2011;58(2):389-399. doi:10.1016/j.pcl.2011.02.008.

4. Slusher TM, Vreman HJ, Wong RJ, Stevenson DK. Burden of severe neonatal jaundice: A systematic review and meta-analysis. Journal of Pediatrics. 2014;164(4):758-765. doi:10.1016/j.jpeds.2013.11.015.

5. Dennery PA, Seidman DS, Stevenson DK. Neonatal hyperbilirubinemia: Mechanisms and management. Journal of Perinatology. 2001;21(6):441-446. doi:10.1038/sj.jp.7210543.

6. Johnson L, Bhutani VK. The clinical significance of bilirubin levels in the newborn. Seminars in Fetal & Neonatal Medicine. 2012;17(3):130-137. doi:10.1016/j.siny.2012.02.002.

7. Kernicterus Registry Report. Chronic bilirubin encephalopathy. Journal of Pediatrics. 2010;157(4):681-684. doi:10.1016/j.jpeds.2010.03.050.

8. American Academy of Pediatrics (AAP). Guidelines for management of hyperbilirubinemia in newborn infants 35 or more weeks of gestation. Pediatrics. 2004;114(1):297-316. doi:10.1542/peds.114.1.297.

9. Gartner LM, Herschel M. Practice parameters for the management of hyperbilirubinemia. Pediatrics. 2001;108(3):803-806. doi:10.1542/peds.108.3.803.

10. Shapiro SM. Bilirubin toxicity in the developing nervous system. Pediatric Neurology. 2005;33(1):1-11. doi:10.1016/j.pediatrneurol.2005.02.009.

11. Baker JP. Historical perspectives on neonatal jaundice and kernicterus. Pediatrics. 2002;110(4):837-838. doi:10.1542/peds.110.4.837.

12. U.S. Preventive Services Task Force. Screening for hyperbilirubinemia in newborns: Recommendation statement. Annals of Family Medicine. 2009;7(6):536- 540. doi:10.1370/afm.1088.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Indexed In · Partners

Trusted by Global Scientific Indexing Services

JUSR is indexed and recognized by leading international databases and research integrity organizations.